Cumberland Pharmaceuticals Stock Annual Yield

CPIX Stock  USD 1.79  0.08  4.68%   
Cumberland Pharmaceuticals fundamentals help investors to digest information that contributes to Cumberland Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Cumberland Stock. The fundamental analysis module provides a way to measure Cumberland Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cumberland Pharmaceuticals stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cumberland Annual Yield Analysis

Cumberland Pharmaceuticals' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total16.1M21.0M18.4M11.9M
Total Assets84.5M92.9M81.8M88.1M

Yield

 = 

Income from Security

Current Share Price

More About Annual Yield | All Equity Analysis

Cumberland Annual Yield Driver Correlations

Understanding the fundamental principles of building solid financial models for Cumberland Pharmaceuticals is extremely important. It helps to project a fair market value of Cumberland Stock properly, considering its historical fundamentals such as Annual Yield. Since Cumberland Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cumberland Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cumberland Pharmaceuticals' interrelated accounts and indicators.
0.530.640.87-0.230.390.330.490.57-0.090.430.750.170.660.130.250.40.760.22-0.310.270.10.02-0.15-0.01
0.53-0.140.490.45-0.250.620.740.50.250.790.04-0.140.820.570.550.650.070.21-0.710.630.0-0.43-0.56-0.18
0.64-0.140.53-0.820.85-0.38-0.180.05-0.3-0.420.940.33-0.05-0.61-0.5-0.410.91-0.30.45-0.540.050.490.510.25
0.870.490.53-0.10.140.50.510.57-0.050.40.60.10.570.220.150.320.680.23-0.470.250.19-0.36-0.39-0.36
-0.230.45-0.82-0.1-0.850.740.40.060.560.7-0.74-0.40.480.880.750.64-0.750.52-0.810.730.0-0.65-0.8-0.55
0.39-0.250.850.14-0.85-0.63-0.35-0.16-0.18-0.540.740.46-0.13-0.8-0.51-0.520.72-0.440.69-0.640.00.810.830.69
0.330.62-0.380.50.74-0.630.730.530.340.84-0.23-0.070.710.860.730.79-0.250.58-0.950.820.33-0.71-0.87-0.65
0.490.74-0.180.510.4-0.350.730.670.040.79-0.02-0.010.680.550.530.70.080.53-0.720.630.16-0.54-0.63-0.3
0.570.50.050.570.06-0.160.530.67-0.380.620.260.240.490.370.30.650.290.19-0.510.570.35-0.35-0.4-0.17
-0.090.25-0.3-0.050.56-0.180.340.04-0.380.25-0.380.010.40.290.320.15-0.410.14-0.360.20.15-0.17-0.23-0.14
0.430.79-0.420.40.7-0.540.840.790.620.25-0.22-0.190.840.870.880.96-0.170.62-0.890.950.06-0.55-0.79-0.31
0.750.040.940.6-0.740.74-0.23-0.020.26-0.38-0.220.330.05-0.43-0.36-0.170.91-0.290.32-0.310.10.430.380.21
0.17-0.140.330.1-0.40.46-0.07-0.010.240.01-0.190.33-0.01-0.44-0.35-0.150.21-0.310.23-0.210.850.380.460.32
0.660.82-0.050.570.48-0.130.710.680.490.40.840.05-0.010.620.740.750.090.47-0.770.680.11-0.28-0.53-0.16
0.130.57-0.610.220.88-0.80.860.550.370.290.87-0.43-0.440.620.880.87-0.450.65-0.910.92-0.03-0.68-0.92-0.6
0.250.55-0.50.150.75-0.510.730.530.30.320.88-0.36-0.350.740.880.88-0.340.7-0.760.89-0.14-0.35-0.68-0.21
0.40.65-0.410.320.64-0.520.790.70.650.150.96-0.17-0.150.750.870.88-0.190.6-0.820.970.1-0.44-0.72-0.28
0.760.070.910.68-0.750.72-0.250.080.29-0.41-0.170.910.210.09-0.45-0.34-0.19-0.170.28-0.31-0.070.280.320.26
0.220.21-0.30.230.52-0.440.580.530.190.140.62-0.29-0.310.470.650.70.6-0.17-0.590.61-0.09-0.4-0.63-0.36
-0.31-0.710.45-0.47-0.810.69-0.95-0.72-0.51-0.36-0.890.320.23-0.77-0.91-0.76-0.820.28-0.59-0.84-0.170.780.930.66
0.270.63-0.540.250.73-0.640.820.630.570.20.95-0.31-0.210.680.920.890.97-0.310.61-0.840.07-0.53-0.79-0.33
0.10.00.050.190.00.00.330.160.350.150.060.10.850.11-0.03-0.140.1-0.07-0.09-0.170.07-0.020.01-0.18
0.02-0.430.49-0.36-0.650.81-0.71-0.54-0.35-0.17-0.550.430.38-0.28-0.68-0.35-0.440.28-0.40.78-0.53-0.020.890.78
-0.15-0.560.51-0.39-0.80.83-0.87-0.63-0.4-0.23-0.790.380.46-0.53-0.92-0.68-0.720.32-0.630.93-0.790.010.890.78
-0.01-0.180.25-0.36-0.550.69-0.65-0.3-0.17-0.14-0.310.210.32-0.16-0.6-0.21-0.280.26-0.360.66-0.33-0.180.780.78
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition

Cumberland Dividend Yield

Dividend Yield

0.003307

At this time, Cumberland Pharmaceuticals' Dividend Yield is fairly stable compared to the past year.
In accordance with the recently published financial statements, Cumberland Pharmaceuticals has an Annual Yield of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Cumberland Annual Yield Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cumberland Pharmaceuticals' direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cumberland Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cumberland Pharmaceuticals by comparing valuation metrics of similar companies.
Cumberland Pharmaceuticals is currently under evaluation in annual yield category among related companies.

Cumberland Fundamentals

About Cumberland Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cumberland Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cumberland Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cumberland Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee. Cumberland Pharmaceu operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 83 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cumberland Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cumberland Pharmaceuticals' short interest history, or implied volatility extrapolated from Cumberland Pharmaceuticals options trading.

Pair Trading with Cumberland Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cumberland Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cumberland Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against Cumberland Stock

  0.6YS YS Biopharma Report 22nd of April 2024 PairCorr
  0.45MESO Mesoblast TrendingPairCorr
The ability to find closely correlated positions to Cumberland Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cumberland Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cumberland Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cumberland Pharmaceuticals to buy it.
The correlation of Cumberland Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cumberland Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cumberland Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cumberland Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cumberland Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cumberland Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cumberland Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cumberland Pharmaceuticals Stock:
Check out Cumberland Pharmaceuticals Piotroski F Score and Cumberland Pharmaceuticals Altman Z Score analysis.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Cumberland Stock analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stocks Directory
Find actively traded stocks across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Is Cumberland Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cumberland Pharmaceuticals. If investors know Cumberland will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cumberland Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.44)
Revenue Per Share
2.766
Quarterly Revenue Growth
0.025
Return On Assets
(0.04)
Return On Equity
(0.19)
The market value of Cumberland Pharmaceuticals is measured differently than its book value, which is the value of Cumberland that is recorded on the company's balance sheet. Investors also form their own opinion of Cumberland Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cumberland Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cumberland Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cumberland Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cumberland Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cumberland Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cumberland Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.